Top 10 Pharmaceutical Companies by Revenue (2022)
Oct 3, 2024
2 min read
0
9
0
Here's a list of top pharmaceutical brands across the globe, categorized by therapy area:
*Top 10 Pharmaceutical Companies by Revenue (2022):*
1. Johnson & Johnson (USA) - $82.06 billion
2. Pfizer (USA) - $78.13 billion
3. Roche (Switzerland) - $64.47 billion
4. Novartis (Switzerland) - $59.18 billion
5. Merck & Co (USA) - $58.67 billion
6. GlaxoSmithKline (UK) - $54.69 billion
7. Sanofi (France) - $53.95 billion
8. AstraZeneca (UK/Sweden) - $52.43 billion
9. Eli Lilly (USA) - $49.74 billion
10. Gilead Sciences (USA) - $48.85 billion
*Top Brands by Therapy Area:*
*Oncology:*
1. Revlimid (Lenalidomide) - Celgene
2. Imbruvica (Ibrutinib) - AbbVie/Johnson & Johnson
3. Opdivo (Nivolumab) - Bristol-Myers Squibb
4. Keytruda (Pembrolizumab) - Merck & Co
5. Herceptin (Trastuzumab) - Roche
*Cardiovascular:*
1. Lipitor (Atorvastatin) - Pfizer
2. Plavix (Clopidogrel) - Sanofi/Bristol-Myers Squibb
3. Crestor (Rosuvastatin) - AstraZeneca
4. Zetia (Ezetimibe) - Merck & Co
5. Diovan (Valsartan) - Novartis
*Neurology:*
1. Lyrica (Pregabalin) - Pfizer
2. Copaxone (Glatiramer Acetate) - Teva
3. Rebif (Interferon beta-1a) - Merck KGaA
4. Avonex (Interferon beta-1a) - Biogen
5. Gilenya (Fingolimod) - Novartis
*Respiratory:*
1. Advair (Fluticasone/Salmeterol) - GlaxoSmithKline
2. Symbicort (Budesonide/Formoterol) - AstraZeneca
3. Spiriva (Tiotropium) - Boehringer Ingelheim/Pfizer
4. Singulair (Montelukast) - Merck & Co
5. Ventolin (Albuterol) - GlaxoSmithKline
*Diabetes:*
1. Humira (Adalimumab) - AbbVie
2. Lantus (Insulin Glargine) - Sanofi
3. Novolog (Insulin Aspart) - Novo Nordisk
4. Levemir (Insulin Detemir) - Novo Nordisk
5. Januvia (Sitagliptin) - Merck & Co
*Generic Pharmaceutical Companies:*
1. Teva (Israel)
2. Sandoz (Novartis, Switzerland)
3. Mylan (USA)
4. Hospira (Pfizer, USA)
5. Fresenius Kabi (Germany)
*Biotechnology Companies:*
1. Amgen (USA)
2. Biogen (USA)
3. Gilead Sciences (USA)
4. Celgene (USA)
5. Regeneron Pharmaceuticals (USA)